Imaging markers of intracerebral hemorrhage expansion in patients with unclear symptom onset
暂无分享,去创建一个
S. Greenberg | A. Charidimou | A. Padovani | J. Goldstein | A. Viswanathan | J. Rosand | G. Boulouis | A. Pezzini | E. Fainardi | A. Morotti | F. Arba | R. Gasparotti | E. Gurol | A. Cavallini | I. Casetta | M. Magoni | M. Fontanella | V. D. Giuli | L. Simonetti | Federico Mazzacane | G. Busto | Andrew D. Warren | P. Costa | A. Zini | C. Cornali | Michele Laudisi | L. Poli | M. Gamba | Eleonora Leuci | Sebastiano Giacomozzi | Laura Brancaleoni | F. Mazzacane
[1] S. Greenberg,et al. Hematoma Expansion in Intracerebral Hemorrhage With Unclear Onset , 2021, Neurology.
[2] M. Elkind,et al. Hematoma expansion is more frequent in deep than lobar intracerebral hemorrhage , 2020, Neurology.
[3] A. Charidimou,et al. Noncontrast CT markers of intracerebral hemorrhage expansion and poor outcome , 2020, Neurology.
[4] J. Goldstein,et al. Ultra‐Early Blood Pressure Reduction Attenuates Hematoma Growth and Improves Outcome in Intracerebral Hemorrhage , 2020, Annals of neurology.
[5] Jun Zhang,et al. Letter: Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data[deg]. , 2020, Turkish neurosurgery.
[6] A. Demchuk,et al. Redefining Hematoma Expansion With the Inclusion of Intraventricular Hemorrhage Growth , 2020, Stroke.
[7] L. Cala,et al. Noncontrast Computed Tomography Signs as Predictors of Hematoma Expansion, Clinical Outcome, and Response to Tranexamic Acid in Acute Intracerebral Hemorrhage , 2019, Stroke.
[8] Craig S. Anderson,et al. Standards for Detecting, Interpreting, and Reporting Noncontrast Computed Tomographic Markers of Intracerebral Hemorrhage Expansion , 2019, Annals of neurology.
[9] C. Cordonnier,et al. Is Hyperselection of Patients the Right Strategy? , 2019, JAMA neurology.
[10] A. Demchuk,et al. Effect of Recombinant Activated Coagulation Factor VII on Hemorrhage Expansion Among Patients With Spot Sign-Positive Acute Intracerebral Hemorrhage: The SPOTLIGHT and STOP-IT Randomized Clinical Trials. , 2019, JAMA neurology.
[11] A. Demchuk,et al. Interrater and Intrarater Measurement Reliability of Noncontrast Computed Tomography Predictors of Intracerebral Hemorrhage Expansion , 2019, Stroke.
[12] E. Heuvel,et al. Testing homogeneity of effect sizes in pooling 2x2 contingency tables from multiple studies: a comparison of methods , 2018 .
[13] Javier M Romero,et al. Blood pressure reduction and noncontrast CT markers of intracerebral hemorrhage expansion , 2017, Neurology.
[14] S. Greenberg,et al. Intensive Blood Pressure Reduction and Spot Sign in Intracerebral Hemorrhage: A Secondary Analysis of a Randomized Clinical Trial , 2017, JAMA neurology.
[15] J. Teitelbaum,et al. Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage , 2016, Neurocritical Care.
[16] Mario Zuccarello,et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2015, Stroke.
[17] G. Fink,et al. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. , 2015, JAMA.
[18] S. Greenberg,et al. Predicting hematoma expansion after primary intracerebral hemorrhage. , 2014, JAMA neurology.
[19] R. Salman,et al. Eligibility for randomized trials of treatments specifically for intracerebral hemorrhage: community-based study , 2013, Trials.
[20] S. Greenberg,et al. CTA Spot Sign Predicts Hematoma Expansion in Patients with Delayed Presentation After Intracerebral Hemorrhage , 2012, Neurocritical Care.
[21] Eric E. Smith,et al. Defining hematoma expansion in intracerebral hemorrhage , 2011, Neurology.
[22] Y. Fujii,et al. Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data , 2018 .